The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens
Abstract
The human immunodeficiency virus–type 1 (HIV-1) envelope glycoproteins interact with receptors on the target cell and mediate virus entry by fusing the viral and cell membranes. The structure of the envelope glycoproteins has evolved to fulfill these functions while evading the neutralizing antibody response. An understanding of the viral strategies for immune evasion should guide attempts to improve the immunogenicity of the HIV-1 envelope glycoproteins and, ultimately, aid in HIV-1 vaccine development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Samson, M., Libert, F., Doranz, B. J., Rucker, J., Liesnard, C., Farber, C.-M., Saragosti, S., Lapouméroulie, C., Cognaux, J., Forceille, C., et al. (1996) · Nature · doi:10.1038/382722a0 · Cited by 2,886
CC CKR5: A RANTES, MIP-1α, MIP-1β Receptor as a Fusion Cofactor for Macrophage-Tropic HIV-1
Alkhatib, G., Combadiere, C., Broder, C. C., Feng, Y., Kennedy, P. E., Murphy, P. M., & Berger, E. A. (1996) · Science · doi:10.1126/science.272.5270.1955 · Cited by 2,706
T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV
Klatzmann, D., Champagne, E., Chamaret, S., Gruest, J., Guetard, D., Hercend, T., Gluckman, J.-C., & Montagnier, L. (1984) · Nature · doi:10.1038/312767a0 · Cited by 2,436
Close Contacts with the Endoplasmic Reticulum as Determinants of Mitochondrial Ca 2+ Responses
Rizzuto, R., Pinton, P., Carrington, W., Fay, F. S., Fogarty, K. E., Lifshitz, L. M., Tuft, R. A., & Pozzan, T. (1998) · Science · doi:10.1126/science.280.5370.1763 · Cited by 2,257
Atomic structure of the ectodomain from HIV-1 gp41
Weissenhorn, W., Dessen, A., Harrison, S. C., Skehel, J. J., & Wiley, D. C. (1997) · Nature · doi:10.1038/387426a0 · Cited by 1,622
Quantitation of Human Immunodeficiency Virus Type 1 in the Blood of Infected Persons
Ho, D. D., Moudgil, T., & Alam, M. (1989) · New England Journal of Medicine · doi:10.1056/nejm198912143212401 · Cited by 1,064
Leonard, C. K., Spellman, M. W., Riddle, L., Harris, R. J., Thomas, J. N., & Gregory, T. J. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)86956-3 · Cited by 985
Functional Regions of the Envelope Glycoprotein of Human Immunodeficiency Virus Type 1
Kowalski, M., Potz, J., Basiripour, L., Dorfman, T., Goh, W. C., Terwilliger, E., Dayton, A., Rosen, C., Haseltine, W., & Sodroski, J. (1987) · Science · doi:10.1126/science.3629244 · Cited by 848
Self-citationStarcich, B. R., Hahn, B. H., Shaw, G. M., McNeely, P. D., Modrow, S., Wolf, H., Parks, E. S., Parks, W. P., Josephs, S. F., Gallo, R. C., et al. (1986) · Cell · doi:10.1016/0092-8674(86)90778-6 · Cited by 767
Thali, M., Moore, J. P., Furman, C., Charles, M., Ho, D. D., Robinson, J., & Sodroski, J. (1993) · Journal of Virology · doi:10.1128/jvi.67.7.3978-3988.1993 · Cited by 616
Self-citation
Cited by
Antibody neutralization and escape by HIV-1
Wei, X., Decker, J. M., Wang, S., Hui, H., Kappes, J. C., Wu, X., Salazar-Gonzalez, J. F., Salazar, M. G., Kilby, J. M., Saag, M. S., et al. (2003) · Nature · doi:10.1038/nature01470 · Cited by 2,421
Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease
Berger, E. A., Murphy, P. M., & Farber, J. M. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.657 · Cited by 2,180
Mechanisms of Viral Membrane Fusion and Its Inhibition
Eckert, D. M., & Kim, P. S. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.777 · Cited by 1,282
Membrane Fusion and Exocytosis
Jahn, R., & Südhof, T. C. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.863 · Cited by 1,259
Li, M., Gao, F., Mascola, J. R., Stamatatos, L., Polonis, V. R., Koutsoukos, M., Voss, G., Goepfert, P., Gilbert, P., Greene, K. M., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.16.10108-10125.2005 · Cited by 1,070
Mode of antiviral action of silver nanoparticles against HIV-1
Lara, H. H., Ayala-Nuñez, N. V., Ixtepan-Turrent, L., & Rodriguez-Padilla, C. (2010) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-8-1 · Cited by 1,061
Crystal Structure of a Neutralizing Human IgG Against HIV-1: A Template for Vaccine Design
Saphire, E. O., Parren, P. W. H. I., Pantophlet, R., Zwick, M. B., Morris, G. M., Rudd, P. M., Dwek, R. A., Stanfield, R. L., Burton, D. R., & Wilson, I. A. (2001) · Science · doi:10.1126/science.1061692 · Cited by 942
Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9
McLellan, J. S., Pancera, M., Carrico, C., Gorman, J., Julien, J.-P., Khayat, R., Louder, R., Pejchal, R., Sastry, M., Dai, K., et al. (2011) · Nature · doi:10.1038/nature10696 · Cited by 830
“ppt"/> As the sole viral target of neutralizing antibodies, the HIV-1 viral spike has evolved to evade antibody-mediated neutralization (reviewed in ref”
Self-citationZwick, M. B., Labrijn, A. F., Wang, M., Spenlehauer, C., Saphire, E. O., Binley, J. M., Moore, J. P., Stiegler, G., Katinger, H., Burton, D. R., et al. (2001) · Journal of Virology · doi:10.1128/jvi.75.22.10892-10905.2001 · Cited by 797
Protein-Lipid Interplay in Fusion and Fission of Biological Membranes
Chernomordik, L. V., & Kozlov, M. M. (2003) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161504 · Cited by 782
Structural definition of a conserved neutralization epitope on HIV-1 gp120
Zhou, T., Xu, L., Dey, B., Hessell, A. J., Van Ryk, D., Xiang, S.-H., Yang, X., Zhang, M.-Y., Zwick, M. B., Arthos, J., et al. (2007) · Nature · doi:10.1038/nature05580 · Cited by 770
Self-citationHIV vaccine design and the neutralizing antibody problem
Burton, D. R., Desrosiers, R. C., Doms, R. W., Koff, W. C., Kwong, P. D., Moore, J. P., Nabel, G. J., Sodroski, J., Wilson, I. A., & Wyatt, R. T. (2004) · Nature Immunology · doi:10.1038/ni0304-233 · Cited by 765
Self-citationStructure and immune recognition of trimeric pre-fusion HIV-1 Env
Pancera, M., Zhou, T., Druz, A., Georgiev, I. S., Soto, C., Gorman, J., Huang, J., Acharya, P., Chuang, G.-Y., Ofek, G., et al. (2014) · Nature · doi:10.1038/nature13808 · Cited by 740
Structure of a V3-Containing HIV-1 gp120 Core
Huang, C.-C., Tang, M., Zhang, M.-Y., Majeed, S., Montabana, E., Stanfield, R. L., Dimitrov, D. S., Korber, B., Sodroski, J., Wilson, I. A., et al. (2005) · Science · doi:10.1126/science.1118398 · Cited by 731
Self-citationHIV/AIDS epidemiology, pathogenesis, prevention, and treatment
Simon, V., Ho, D. D., & Abdool Karim, Q. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69157-5 · Cited by 730
Macrophage inflammatory protein-1
Menten, P., Wuyts, A., & Van Damme, J. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(02)00045-x · Cited by 706
A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield
Pejchal, R., Doores, K. J., Walker, L. M., Khayat, R., Huang, P.-S., Wang, S.-K., Stanfield, R. L., Julien, J.-P., Ramos, A., Crispin, M., et al. (2011) · Science · doi:10.1126/science.1213256 · Cited by 694
Scanlan, C. N., Pantophlet, R., Wormald, M. R., Saphire, E. O., Stanfield, R., Wilson, I. A., Katinger, H., Dwek, R. A., Rudd, P. M., & Burton, D. R. (2002) · Journal of Virology · doi:10.1128/jvi.76.14.7306-7321.2002 · Cited by 665
Measuring HIV Neutralization in a Luciferase Reporter Gene Assay
Montefiori, D. C. (2009) · Methods in Molecular Biology · doi:10.1007/978-1-59745-170-3_26 · Cited by 583
Evaluating Neutralizing Antibodies Against HIV, SIV, and SHIV in Luciferase Reporter Gene Assays
Montefiori, D. C. (2004) · Current Protocols in Immunology · doi:10.1002/0471142735.im1211s64 · Cited by 580
Melikyan, G. B., Markosyan, R. M., Hemmati, H., Delmedico, M. K., Lambert, D. M., & Cohen, F. S. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.151.2.413 · Cited by 576
Kenakin, T., & Miller, L. J. (2010) · Pharmacological Reviews · doi:10.1124/pr.108.000992 · Cited by 573
Sanders, R. W., Venturi, M., Schiffner, L., Kalyanaraman, R., Katinger, H., Lloyd, K. O., Kwong, P. D., & Moore, J. P. (2002) · Journal of Virology · doi:10.1128/jvi.76.14.7293-7305.2002 · Cited by 553
Structure of an unliganded simian immunodeficiency virus gp120 core
Chen, B., Vogan, E. M., Gong, H., Skehel, J. J., Wiley, D. C., & Harrison, S. C. (2005) · Nature · doi:10.1038/nature03327 · Cited by 520
Inhibiting sexual transmission of HIV-1 infection
Shattock, R. J., & Moore, J. P. (2003) · Nature Reviews Microbiology · doi:10.1038/nrmicro729 · Cited by 505
Conformational dynamics of single HIV-1 envelope trimers on the surface of native virions
Munro, J. B., Gorman, J., Ma, X., Zhou, Z., Arthos, J., Burton, D. R., Koff, W. C., Courter, J. R., Smith, A. B., Kwong, P. D., et al. (2014) · Science · doi:10.1126/science.1254426 · Cited by 492
Zhang, M. (2004) · Glycobiology · doi:10.1093/glycob/cwh106 · Cited by 483
HIV‐1 neutralizing antibodies: understanding nature's pathways
Mascola, J. R., & Haynes, B. F. (2013) · Immunological Reviews · doi:10.1111/imr.12075 · Cited by 475
Structural biology of HIV 1 1Edited by P. E. Wright
Turner, B. G., & Summers, M. F. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.2354 · Cited by 470
Enfuvirtide: the first therapy to inhibit the entry of HIV-1 into host CD4 lymphocytes
Matthews, T., Salgo, M., Greenberg, M., Chung, J., DeMasi, R., & Bolognesi, D. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1331 · Cited by 465
Human Antibodies that Neutralize HIV-1: Identification, Structures, and B Cell Ontogenies
Kwong, P. D., & Mascola, J. R. (2012) · Immunity · doi:10.1016/j.immuni.2012.08.012 · Cited by 455
Cardoso, R. M. F., Zwick, M. B., Stanfield, R. L., Kunert, R., Binley, J. M., Katinger, H., Burton, D. R., & Wilson, I. A. (2005) · Immunity · doi:10.1016/j.immuni.2004.12.011 · Cited by 449
GP120: Target for Neutralizing HIV-1 Antibodies
Pantophlet, R., & Burton, D. R. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090557 · Cited by 445
Sanders, R. W., Vesanen, M., Schuelke, N., Master, A., Schiffner, L., Kalyanaraman, R., Paluch, M., Berkhout, B., Maddon, P. J., Olson, W. C., et al. (2002) · Journal of Virology · doi:10.1128/jvi.76.17.8875-8889.2002 · Cited by 440
Zhu, P., Chertova, E., Bess, J., Lifson, J. D., Arthur, L. O., Liu, J., Taylor, K. A., & Roux, K. H. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2634931100 · Cited by 431
Structures of the CCR5 N Terminus and of a Tyrosine-Sulfated Antibody with HIV-1 gp120 and CD4
Huang, C.-C., Lam, S. N., Acharya, P., Tang, M., Xiang, S.-H., Hussan, S. S.-U., Stanfield, R. L., Robinson, J., Sodroski, J., Wilson, I. A., et al. (2007) · Science · doi:10.1126/science.1145373 · Cited by 416
Self-citationAzaphilones: Chemistry and Biology
Gao, J.-M., Yang, S.-X., & Qin, J.-C. (2013) · Chemical Reviews · doi:10.1021/cr300402y · Cited by 409
Recent progress in broadly neutralizing antibodies to HIV
Sok, D., & Burton, D. R. (2018) · Nature Immunology · doi:10.1038/s41590-018-0235-7 · Cited by 407
Trimeric HIV-1-Env Structures Define Glycan Shields from Clades A, B, and G
Stewart-Jones, G. B. E., Soto, C., Lemmin, T., Chuang, G.-Y., Druz, A., Kong, R., Thomas, P. V., Wagh, K., Zhou, T., Behrens, A.-J., et al. (2016) · Cell · doi:10.1016/j.cell.2016.04.010 · Cited by 404
The HIV Env-mediated fusion reaction
Gallo, S. A., Finnegan, C. M., Viard, M., Raviv, Y., Dimitrov, A., Rawat, S. S., Puri, A., Durell, S., & Blumenthal, R. (2003) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(03)00161-5 · Cited by 391
Structures of HIV-1 gp120 Envelope Glycoproteins from Laboratory-Adapted and Primary Isolates
Kwong, P. D., Wyatt, R., Majeed, S., Robinson, J., Sweet, R. W., Sodroski, J., & Hendrickson, W. A. (2000) · Structure · doi:10.1016/s0969-2126(00)00547-5 · Cited by 390
Self-citationMellado, M., Rodríguez-Frade, J. M., Mañes, S., & Martínez-A, C. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.397 · Cited by 390
The Role of Antibodies in HIV Vaccines
Mascola, J. R., & Montefiori, D. C. (2010) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101256 · Cited by 388
Broad HIV-1 neutralization mediated by CD4-binding site antibodies
Li, Y., Migueles, S. A., Welcher, B., Svehla, K., Phogat, A., Louder, M. K., Wu, X., Shaw, G. M., Connors, M., Wyatt, R. T., et al. (2007) · Nature Medicine · doi:10.1038/nm1624 · Cited by 383
Self-citationA Blueprint for HIV Vaccine Discovery
Burton, D. R., Ahmed, R., Barouch, D. H., Butera, S. T., Crotty, S., Godzik, A., Kaufmann, D. E., McElrath, M. J., Nussenzweig, M. C., Pulendran, B., et al. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.09.008 · Cited by 375
Self-citationLi, M., Salazar-Gonzalez, J. F., Derdeyn, C. A., Morris, L., Williamson, C., Robinson, J. E., Decker, J. M., Li, Y., Salazar, M. G., Polonis, V. R., et al. (2006) · Journal of Virology · doi:10.1128/jvi.01730-06 · Cited by 359
Labrijn, A. F., Poignard, P., Raja, A., Zwick, M. B., Delgado, K., Franti, M., Binley, J., Vivona, V., Grundner, C., Huang, C.-C., et al. (2003) · Journal of Virology · doi:10.1128/jvi.77.19.10557-10565.2003 · Cited by 357
Self-citationA small molecule HIV-1 inhibitor that targets the HIV-1 envelope and inhibits CD4 receptor binding
Lin, P.-F., Blair, W., Wang, T., Spicer, T., Guo, Q., Zhou, N., Gong, Y.-F., Wang, H.-G. H., Rose, R., Yamanaka, G., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1832214100 · Cited by 357
Do Kwon, Y., Pancera, M., Acharya, P., Georgiev, I. S., Crooks, E. T., Gorman, J., Joyce, M. G., Guttman, M., Ma, X., Narpala, S., et al. (2015) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3051 · Cited by 345
Nature of Nonfunctional Envelope Proteins on the Surface of Human Immunodeficiency Virus Type 1
Moore, P. L., Crooks, E. T., Porter, L., Zhu, P., Cayanan, C. S., Grise, H., Corcoran, P., Zwick, M. B., Franti, M., Morris, L., et al. (2006) · Journal of Virology · doi:10.1128/jvi.80.5.2515-2528.2006 · Cited by 343
The challenges of eliciting neutralizing antibodies to HIV-1 and to influenza virus
Karlsson Hedestam, G. B., Fouchier, R. A. M., Phogat, S., Burton, D. R., Sodroski, J., & Wyatt, R. T. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1819 · Cited by 339
Self-citationPancera, M., Majeed, S., Ban, Y.-E. A., Chen, L., Huang, C.-C., Kong, L., Kwon, Y. D., Stuckey, J., Zhou, T., Robinson, J. E., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911004107 · Cited by 338
Self-citationWalker, B. D., & Burton, D. R. (2008) · Science · doi:10.1126/science.1152622 · Cited by 338
Viral exploitation and subversion of the immune system through chemokine mimicry
Murphy, P. M. (2001) · Nature Immunology · doi:10.1038/84214 · Cited by 336
Jelinek, R., & Kolusheva, S. (2004) · Chemical Reviews · doi:10.1021/cr0300284 · Cited by 334
Broadly neutralizing antibodies and the search for an HIV-1 vaccine: the end of the beginning
Kwong, P. D., Mascola, J. R., & Nabel, G. J. (2013) · Nature Reviews Immunology · doi:10.1038/nri3516 · Cited by 329
New Concepts in Drug Discovery: Collateral Efficacy and Permissive Antagonism
Kenakin, T. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1875 · Cited by 317
The origins of acquired immune deficiency syndrome viruses: where and when?
Sharp, P. M., Bailes, E., Chaudhuri, R. R., Rodenburg, C. M., Santiago, M. O., & Hahn, B. H. (2001) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.2001.0863 · Cited by 317
Molecular Mechanism of HIV-1 Entry
Chen, B. (2019) · Trends in Microbiology · doi:10.1016/j.tim.2019.06.002 · Cited by 316
Watson, C., Jenkinson, S., Kazmierski, W., & Kenakin, T. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.008565 · Cited by 302
Antibody vs. HIV in a clash of evolutionary titans
Burton, D. R., Stanfield, R. L., & Wilson, I. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505126102 · Cited by 299
Moulard, M., Lortat-Jacob, H., Mondor, I., Roca, G., Wyatt, R., Sodroski, J., Zhao, L., Olson, W., Kwong, P. D., & Sattentau, Q. J. (2000) · Journal of Virology · doi:10.1128/jvi.74.4.1948-1960.2000 · Cited by 297
Self-citationDoms, R. W., & Moore, J. P. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.151.2.f9 · Cited by 296
Antigenic conservation and immunogenicity of the HIV coreceptor binding site
Decker, J. M., Bibollet-Ruche, F., Wei, X., Wang, S., Levy, D. N., Wang, W., Delaporte, E., Peeters, M., Derdeyn, C. A., Allen, S., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042510 · Cited by 295
Montefiori, D. C., Karnasuta, C., Huang, Y., Ahmed, H., Gilbert, P., de Souza, M. S., McLinden, R., Tovanabutra, S., Laurence-Chenine, A., Sanders-Buell, E., et al. (2012) · Journal of Infectious Diseases · doi:10.1093/infdis/jis367 · Cited by 284
The entry of entry inhibitors: A fusion of science and medicine
Moore, J. P., & Doms, R. W. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1932511100 · Cited by 278
Bell, D., Young, J. W., & Banchereau, J. (1999) · Advances in Immunology · doi:10.1016/s0065-2776(08)60023-1 · Cited by 277
Structural basis for diverse N-glycan recognition by HIV-1–neutralizing V1–V2–directed antibody PG16
Pancera, M., Shahzad-ul-Hussan, S., Doria-Rose, N. A., McLellan, J. S., Bailer, R. T., Dai, K., Loesgen, S., Louder, M. K., Staupe, R. P., Yang, Y., et al. (2013) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2600 · Cited by 270
Zhou, J., Swiderski, P., Li, H., Zhang, J., Neff, C. P., Akkina, R., & Rossi, J. J. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp185 · Cited by 267
Novel Therapies Based on Mechanisms of HIV-1 Cell Entry
Kilby, J. M., & Eron, J. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmra022812 · Cited by 254
Montero, M., van Houten, N. E., Wang, X., & Scott, J. K. (2008) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00020-07 · Cited by 253
Mechanism of Neutralization by the Broadly Neutralizing HIV-1 Monoclonal Antibody VRC01
Li, Y., O'Dell, S., Walker, L. M., Wu, X., Guenaga, J., Feng, Y., Schmidt, S. D., McKee, K., Louder, M. K., Ledgerwood, J. E., et al. (2011) · Journal of Virology · doi:10.1128/jvi.00754-11 · Cited by 235
Self-citationWang, W., Nie, J., Prochnow, C., Truong, C., Jia, Z., Wang, S., Chen, X. S., & Wang, Y. (2013) · Retrovirology · doi:10.1186/1742-4690-10-14 · Cited by 114
“Background The human immunodeficiency virus type 1 (HIV-1) Env consists of a trimer of heterodimers of the gp120 surface protein and the gp41 transmembrane protein [1-3].”
Melby, T., DeSpirito, M., DeMasi, R., Heilek‐Snyder, G., Greenberg, M. L., & Graham, N. (2006) · The Journal of Infectious Diseases · doi:10.1086/504693 · Cited by 112
Peptides for Vaccine Development
Hamley, I. W. (2022) · ACS Applied Bio Materials · doi:10.1021/acsabm.1c01238 · Cited by 104
Current concepts regarding the HTLV-1 receptor complex
Ghez, D., Lepelletier, Y., Jones, K. S., Pique, C., & Hermine, O. (2010) · Retrovirology · doi:10.1186/1742-4690-7-99 · Cited by 73
Nguyen, H. T., Wang, Q., Anang, S., & Sodroski, J. G. (2023) · Journal of Virology · doi:10.1128/jvi.01857-22 · Cited by 19
Self-citationMurakami, T., & Ono, A. (2021) · Current Opinion in Virology · doi:10.1016/j.coviro.2021.07.005 · Cited by 16
Conformational landscape of HIV-1 Env from closed to fully open
Cui, J., Lin, Z. J., Ghosh, S., Du, J., Sadeesh, R., Weiner, D. B., & Pallesen, J. (2026) · Nature Communications · doi:10.1038/s41467-026-69921-z · Cited by 1
Metadata
- Authors
- Wyatt, R., & Sodroski, J.
- Venue
- Science
- Published
- 1998-06-19
- Volume
- 280
- Issue
- 5371
- Pages
- 1884-1888
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1995355944
- Cited by
- 1,598
- References
- 30
- FWCI
- 17.77
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.